Rompe Tos X Children Syrup
NDC Package 69729-784-06
Package Information
Rompe Tos X Children (acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl) syrups is do not take more than directed (see Overdose warning)do not take more than 6 doses in any 24 hour periodmeasure only with dosing cup provideddo not use dosing cup with other productsdose as follows or as directed by a doctormL = millilitertsp = teaspoonfulAgeDoseChildren 6 to under 12 years of age10 mL or 2 tsp provided every 4 hoursChildren under 6 years of agedo not use. This formulation utilizes a syrup delivery system. Marketed by Opmx Llc, this product is identified by NDC 69729-784 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1790651 - acetaminophen 250 MG / dextromethorphan HBr 13.33 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG in 10 mL Oral Solution
- RxCUI: 1790651 - acetaminophen 25 MG/ML / dextromethorphan hydrobromide 1.33 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1790651 - acetaminophen 250 MG / dextromethorphan HBr 13.33 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution
- RxCUI: 1790651 - acetaminophen 500 MG / dextromethorphan HBr 26.66 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution
- RxCUI: 1790651 - APAP 25 MG/ML / Dextromethorphan Hydrobromide 1.33 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 69729 - Opmx Llc
- 69729-784 - Rompe Tos X Children
- 69729-784-06 - 1 BOTTLE, PLASTIC in 1 CARTON / 177 mL in 1 BOTTLE, PLASTIC
- 69729-784 - Rompe Tos X Children
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69729-784-06 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 177 ml in 1 bottle, plastic of Rompe Tos X Children, a human over the counter drug labeled by Opmx Llc. This syrup is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Opmx Llc on September 18, 2023. The current certification is valid through December 31, 2026.
How is this Opmx Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69729078406. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.